Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis

References

• Di Meglio P, Villanova F, Nestle FO. Psoriasis. Cold Spring Harb Perspect Med. 2014;4(8):a015354.
   PubMed Web of Science ®Google Scholar
• Parnami N, Garg T, Rath G, et al. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol. 2014;42(6):406–412.
   PubMed Web of Science ®Google Scholar
• Saleem S, Iqubal MK, Garg S, et al. Expert Opinion on Drug Delivery Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis. Expert Opin Drug Deliv. 2020;17(6):817–838.
   PubMed Web of Science ®Google Scholar
• Singhvi G, Hejmady S, Rapalli VK, et al. Nanocarriers for topical delivery in psoriasis. In: Delivery of drugs. Vol. 2, Expectations and realities of multifunctional drug delivery systems. Ranjita Shegokar editors, Amsterdam (Netherlands): Elsevier Inc; 2020. p. 75–96.
   Google Scholar
• Mason A, Mason J, Cork M, et al. Topical treatments for chronic plaque psoriasis: an abridged Cochrane systematic review. J Am Acad Dermatol. 2013;69(5):799–807.
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Wan J, Callis Duffin K, et al. Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. Arch Dermatol. 2012;148(4):487–494.
   PubMedGoogle Scholar
• Syed ZU, Khachemoune A. Inverse psoriasis: case presentation and review. Am J Clin Dermatol. 2011;12(2):143–146.
   PubMed Web of Science ®Google Scholar
• Yazici AC, Karabulut AA, Özen Ö, et al. Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study. J Dermatol. 2007;34(6):367–374.
   PubMed Web of Science ®Google Scholar
• Rym BM, Mourad M, Bechir Z, et al. Erythroderma in adults: a report of 80 cases. Int J Dermatol. 2005;44(9):731–735.
   PubMed Web of Science ®Google Scholar
• Viguier M, Aubin F, Delaporte E, et al. Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis. Arch Dermatol. 2012;148(12):1423–1425.
   PubMedGoogle Scholar
• Alwan W, Nestle FO. Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. Clin Exp Rheumatol. 2015;33(17):2–6.
   Google Scholar
• Grozdev I, Korman N, Tsankov N. Psoriasis as a systemic disease. Clin Dermatol. 2014;32(3):343–350.
   PubMed Web of Science ®Google Scholar
• Dutta S, Chawla S, Kumar S. Psoriasis: a review of existing therapies and recent advances in treatment. J Ration Pharmacother Res. 2018;4(1):2018.
   Google Scholar
• Souto EB, Baldim I, Oliveira WP, et al. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opin Drug Deliv. 2020;17(3):357–377.
   PubMed Web of Science ®Google Scholar
• Naseri N, Valizadeh H, Zakeri-Milani P. Solid lipid nanoparticles and nanostructured lipid carriers: structure preparation and application. Adv Pharm Bull. 2015;5(3):305–313.
   PubMed Web of Science ®Google Scholar
• Mendes IT, Ruela ALM, Carvalho FC, et al. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. Colloids Surf B Biointerfaces. 2019;177:274–281.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Zhai G. Advances in lipid-based colloid systems as drug carrier for topic delivery. J Control Release. 2014;193:90–99.
   PubMed Web of Science ®Google Scholar
• Sala M, Diab R, Elaissari A, et al. Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications.Int. J. Pharm. 2018;535(1–2):1–17.
   Google Scholar
• Teeranachaideekul V, Boonme P, Souto EB, et al. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J Control Release. 2008;128(2):134–141.
   PubMed Web of Science ®Google Scholar
• Mishra V, Bansal KK, Verma A, et al. Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics. 2018;10(4):1–21.
   Web of Science ®Google Scholar
• Jensen LB, Petersson K, Nielsen HM. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. Eur J Pharm Biopharm. 2011;79(1):68–75.
   PubMed Web of Science ®Google Scholar
• Adib ZM, Ghanbarzadeh S, Kouhsoltani M, et al. The effect of particle size on the deposition of solid lipid nanoparticles in different skin layers: a histological study. Adv Pharm Bull. 2016;6(1):31–36.
   PubMed Web of Science ®Google Scholar
• Otberg N, Teichmann A, Rasuljev U, et al. Follicular penetration of topically applied caffeine via a shampoo formulation. Skin Pharmacol Physiol. 2007;20(4):195–198.
   PubMed Web of Science ®Google Scholar
• Kang JH, Chon J, Kim Y Il, et al. Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution. Int J Nanomedicine. 2019;14:5381–5396.
   PubMed Web of Science ®Google Scholar
• Khezri K, Saeedi M, Morteza-Semnani K, et al. An emerging technology in lipid research for targeting hydrophilic drugs to the skin in the treatment of hyperpigmentation disorders: kojic acid-solid lipid nanoparticles. Artif Cells Nanomed Biotechnol. 2020;48(1):841–853.
   PubMed Web of Science ®Google Scholar
• Czajkowska-Kośnik A, Szekalska M, Winnicka K. Nanostructured lipid carriers: a potential use for skin drug delivery systems. Pharmacol Rep. 2019;71(1):156–166.
   PubMed Web of Science ®Google Scholar
• Ghasemiyeh P, Azadi A, Daneshamouz S, et al. Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting. Pharm Dev Technol. 2019;24(7):812–823.
   PubMed Web of Science ®Google Scholar
• Pinto F, de Barros DPC, Fonseca LP. Design of multifunctional nanostructured lipid carriers enriched with α-tocopherol using vegetable oils. Ind Crops Prod. 2018;118:149–159.
   Web of Science ®Google Scholar
• M Pradhan M, Alexander A, Singh MR, et al. Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacother. 2018;107:447–463.
   PubMed Web of Science ®Google Scholar
• Richards DA, Maruani A, Chudasama V. Antibody fragments as nanoparticle targeting ligands: a step in the right direction. Chem Sci. 2017;8(1):63–77.
   PubMed Web of Science ®Google Scholar
• Kouno M, Lin C, Schechter NM, et al. Targeted delivery of tumor necrosis factor-related apoptosis-inducing ligand to keratinocytes with a pemphigus mAb. J Invest Dermatol. 2013;133(9):2212–2220.
   PubMed Web of Science ®Google Scholar
• DiSepio D, Chandraratna RA. New drugs in the treatment of psoriasis. Expert Opin Investig Drugs. 2000;9(1):79–93.
   PubMed Web of Science ®Google Scholar
• Kim J, Krueger JG. Highly effective new treatments for psoriasis target the IL-23/Type 17 T cell autoimmune axis. Annu Rev Med. 2017;68(1):255–269.
   PubMedGoogle Scholar
• Sivamani RK, Goodarzi H, Garcia MS, et al. Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring. Clin Rev Allergy Immunol. 2013;44(2):121–140.
   PubMed Web of Science ®Google Scholar
• Pincelli C, Schafer PH, French LE, et al. Mechanisms underlying the clinical effects of apremilast for psoriasis. J Drugs Dermatol. 2018;17(8):835–840.
   PubMed Web of Science ®Google Scholar
• Schafer PH, Parton A, Capone L, et al. Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity. Cell Signal. 2014;26(9):2016–2029.
   PubMed Web of Science ®Google Scholar
• Alashqar MB. Caffeine in the treatment of atopic dermatitis and psoriasis: a review. Ski J Cutan Med. 2019;3(2):59–71.
   Google Scholar
• Iriventi P, Gupta NV, Osmani RAM, et al. Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis. DARU J Pharma Sci. 2020;28(2):489–506.
   Web of Science ®Google Scholar
• Ito K, Koga M, and Shibayama Y, et al. Proactive treatment with calcipotriol reduces recurrence of plaque psoriasis. 2016;43(4): 402–405 .
   Google Scholar
• Mason AR, Mason J, Cork M, et al. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev. 2013;(3):CD005028.
   PubMed Web of Science ®Google Scholar
• Rashid MH, Inoue M, Kondo S, et al. Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther. 2003;304(3):940–948.
   PubMed Web of Science ®Google Scholar
• Kim CS, Kawada T, Kim BS, et al. Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages. Cell Signal. 2003;15(3):299–306.
   PubMed Web of Science ®Google Scholar
• Yu C-S. Study on HIF-1α gene translation in psoriatic epidermis with the topical treatment of capsaicin ointment. Int Sch Res Netw Pharm. 2011;2011:821874.
   Google Scholar
• Bernstein JE, Parish LC, Rapaport M, et al. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol. 1986;15(3):504–507.
   PubMed Web of Science ®Google Scholar
• Uva L, Miguel D, Pinheiro C, et al. Mechanisms of action of topical corticosteroids in psoriasis. Int J Endocrinol. 2012;2012:561018.
   PubMed Web of Science ®Google Scholar
• Mcmanus R. Mechanisms of steroid action and resistance in inflammation and disease. J Endocrinol. 2003;178(1):1–4.
   PubMedGoogle Scholar
• De Bosscher K, Berghe WV, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev. 2003;24(4):488–522.
   PubMed Web of Science ®Google Scholar
• Cato AC, Nestl MS, Mink S. Rapid actions of steroid receptors in cellular signaling pathways. Sci STKE. 2002;2002(138). DOI:https://doi.org/10.1126/stke.2002.138.re9
   Google Scholar
• Barygina VV, Becatti M, Soldi G, et al. Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy. Redox Rep. 2013;18(3):100–106.
   PubMed Web of Science ®Google Scholar
• Sun J, Zhao Y, Hu J. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice. PLoS One. 2013;8(6):e67078.
   PubMed Web of Science ®Google Scholar
• Kang D, Li B, Luo L, et al. Curcumin shows excellent therapeutic effect on psoriasis in mouse model. Biochimie. 2016;123:73–80.
   PubMed Web of Science ®Google Scholar
• Varma SR, Sivaprakasam TO, Mishra A, et al. Imiquimod-induced psoriasis-like inflammation in differentiated human keratinocytes: its evaluation using curcumin. Eur J Pharmacol. 2017;813:33–41.
   PubMed Web of Science ®Google Scholar
• Walunj M, Doppalapudi S, Bulbake U, et al. Preparation, characterization and in vivo evaluation of cyclosporine cationic liposomes for the treatment of psoriasis. J Liposome Res. 2020;30(1):68–79.
   PubMed Web of Science ®Google Scholar
• Mohammadi-Samani S, Montaseri H, Jamshidnejad M. Preparation and evaluation of cyproterone acetate liposome for topical drug delivery. Iran J Pharm Sci. 2009;5(4):199–204.
   Google Scholar
• Dogra S, Kaur I. Childhood psoriasis. Indian J Dermatol Venereol Leprol. 2010;76(4):357–365.
   PubMed Web of Science ®Google Scholar
• Laws PM, Young HS. Topical treatment of psoriasis. Expert Opin Pharmacother. 2010 Aug;11(12):1999–2009.
   PubMed Web of Science ®Google Scholar
• Kanelleas A, Liapi C, Katoulis A, et al. The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept. Clin Exp Dermatol. 2011 Dec;36(8):845–850.
   PubMed Web of Science ®Google Scholar
• Gonçalez ML, Corrêa MA, Chorilli M. Skin delivery of kojic acid-loaded nanotechnology-based drug delivery systems for the treatment of skin aging. Biomed Res Int. 2013;2013:271276.
   PubMed Web of Science ®Google Scholar
• Frederick UO, Samson HA. Bioactive lead compounds effective against skin diseases. In: Phytochemicals as Lead Compounds for New Drug Discovery, Chukwuebuka Egbuna, Shashank Kumar, Jonathan C. Ifemeje, Shahira M. Ezzat, Saravanan Kaliyaperumal editors, Amsterdam (Netherlands): Elsevier Inc; 2020. p. 211–220.
   Google Scholar
• Yélamos O, Puig L. Systemic methotrexate for the treatment of psoriasis. Expert Rev Clin Immunol. 2015;11(5):553–563.
   PubMed Web of Science ®Google Scholar
• Laharie D, Terrebonne E, Vergniol J, et al. The liver and methotrexate. Gastroenterol Clin Biol. 2008;32(2):134–142.
   PubMedGoogle Scholar
• Wang T-S, Tsai T-F. Intralesional therapy for psoriasis. J Dermatolog Treat. 2013;24(5):340–347.
   PubMed Web of Science ®Google Scholar
• Tanetsakunwatana T, Tovanabutra N, Kanchanarattanakorn K, et al. Pentoxifylline as add-on therapy in the treatment of moderate to severe psoriasis. Chiang Mai Med J. 2013;52(4):43–50.
   Google Scholar
• Shivatare RS, Phopase ML, Nagore DH, et al. development and validation of hplc analytical protocol for quantification of Salicin from Salix alba L. Invent Rapid Pharm Anal Qual Assur. 2015;2015;(1):1–6.
   Google Scholar
• Vijayalakshmi A, Ravichandiran V, Malarkodi V. Screening of flavonoid “quercetin” from the rhizome of Smilax China Linn. for anti-psoriatic activity. Asian Pac J Trop Biomed. 2012;2(4):269–275.
   PubMedGoogle Scholar
• Jindal S, Awasthi R, Singhare D, et al. Topical delivery of Tacrolimus using liposome containing gel: an emerging and synergistic approach in management of psoriasis. Med Hypotheses. 2020;142:109838.
   PubMed Web of Science ®Google Scholar
• Malecic N, Young H. Tacrolimus for the management of psoriasis: clinical utility and place in therapy. Psoriasis. 2016;6:153.
   PubMedGoogle Scholar
• Rahman M, Akhter S, Ahmad J, et al. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy. Expert Opin on Drug Deliv. 2015;12(4):635–652.
   PubMed Web of Science ®Google Scholar
• Nemati H, Ghahramani MH, Majidi RF, et al. Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis. J Control Release. 2017;268:259–268.
   PubMed Web of Science ®Google Scholar
• Vieira Depieri L, Neves Borgheti-Cardoso L, Mazureki Campos P, et al. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase. Eur J Pharm Biopharm. 2016;105:50–58.
   PubMed Web of Science ®Google Scholar
• Suzuki IL, de Araujo MM, Bagnato VS, et al. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy. J Control Release. 2021;338:316–329.
   PubMed Web of Science ®Google Scholar
• Saelee C, Thongrakard V, Tencomnao T. Effects of Thai medicinal herb extracts with anti-psoriatic activity on the expression on NF-κB signaling biomarkers in HaCaT keratinocytes. Molecules. 2011;16(5):3908–3932.
   PubMed Web of Science ®Google Scholar
• Stücker M, Memmel U, Hoffmann M, et al. Vitamin B(12) cream containing avocado oil in the therapy of plaque psoriasis. Dermatology. 2001;203(2):141–147.
   PubMed Web of Science ®Google Scholar
• Herman A, Herman AP. Topically used herbal products for the treatment of psoriasis - Mechanism of action, drug delivery, clinical studies. Planta Med. 2016;82(17):1447–1455.
   PubMed Web of Science ®Google Scholar
• Najafizadeh P, Hashemian F, Mansouri P, et al. The evaluation of the clinical effect of topical St Johns wort (Hypericum perforatum L.) in plaque type psoriasis vulgaris: a pilot study. Australas J Dermatol. 2012;53(2):131–135.
   PubMed Web of Science ®Google Scholar
• Wu J, Li H, Li M. Effects of baicalin cream in two mouse models: 2,4-dinitrofluorobenzene-induced contact hypersensitivity and mouse tail test for psoriasis. Int J Clin Exp. 2015;8(2):2128.
   PubMed Web of Science ®Google Scholar
• Declercq SD, Pouliot R. Promising new treatments for psoriasis. ScientificWorldJournal. 2013;2013:980419.
   PubMedGoogle Scholar
• Fujiyama T, Ito T, Umayahara T, et al. Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion. J Allergy Clin Immunol. 2016;138(2):517–528.e5.
   PubMed Web of Science ®Google Scholar
• Bhatia A, Singh B, Wadhwa S, et al. Novel phospholipid-based topical formulations of tamoxifen: evaluation for antipsoriatic activity using mouse-tail model. Pharm Dev Technol. 2014;19(2):160–163.
   PubMed Web of Science ®Google Scholar
• Jain A, Doppalapudi S, Domb AJ, et al. Tacrolimus and curcumin co-loaded liposphere gel: synergistic combination towards management of psoriasis. J Control Release. 2016;243:132–145.
   PubMed Web of Science ®Google Scholar
• Cather JC, Crowley JJ. Use of biologic agents in combination with other therapies for the treatment of psoriasis. Am J Clin Dermatol. 2014;15(6):467–478.
   PubMed Web of Science ®Google Scholar
• Dwarampudi LP, Palaniswamy D, Nithyanantham M, et al. Antipsoriatic activity and cytotoxicity of ethanolic extract of Nigella sativa seeds. Pharmacogn Mag. 2012;8(32):268–272.
   PubMed Web of Science ®Google Scholar
• Sahu S, Katiyar SS, Kushwah V, et al. Active natural oil-based nanoemulsion containing tacrolimus for synergistic antipsoriatic efficacy. Nanomedicine (Lond). 2018;13(16):1985–1998.
   PubMed Web of Science ®Google Scholar
• Dos Santos FS, de Souza LP, Siani AC. Chaulmoogra oil as scientific knowledge: the construction of a treatment for leprosy. Hist Cienc Saude Manguinhos. 2008;15(1):29–47.
   PubMed Web of Science ®Google Scholar
• Rajitha P, Shammika P, Aiswarya S, et al. Chaulmoogra oil based methotrexate loaded topical nanoemulsion for the treatment of psoriasis. J Drug Deliv Sci Technol. 2019;49:463–476.
   Web of Science ®Google Scholar
• Burdock GA, Carabin IG. Safety assessment of sandalwood oil (Santalum album L.). Food Chem Toxicol. 2008;46(2):421–432.
   PubMed Web of Science ®Google Scholar
• Sharma M, Levenson C, Clements I, et al. East Indian Sandalwood Oil (EISO) alleviates inflammatory and proliferative pathologies of psoriasis. Front Pharmacol. 2017;8:125.
   PubMed Web of Science ®Google Scholar
• Rai VK, Sinha P, Yadav KS, et al. Anti-psoriatic effect of Lavandula angustifolia essential oil and its major components linalool and linalyl acetate. J Ethnopharmacol. 2020;261(4):113127.
   PubMedGoogle Scholar
• Mondello F, de Bernardis F, Girolamo A, et al. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species. BMC Infect Dis. 2006;6(1):158.
   PubMedGoogle Scholar
• Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev. 2006;19(1):50–62.
   PubMed Web of Science ®Google Scholar
• Chen J, Ma Y, Tao Y, et al. Formulation and evaluation of a topical liposomal gel containing a combination of zedoary turmeric oil and tretinoin for psoriasis activity. J Liposome Res. 2021;31(2):130–144.
   PubMed Web of Science ®Google Scholar
• Marchant R, Banat IM. Biosurfactants: a sustainable replacement for chemical surfactants? Biotechnol Lett. 2012;34(9):1597–1605.
   PubMed Web of Science ®Google Scholar
• Yoon G, Park JW, Yoon IS. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery. J Pharm Investig. 2013;43(5):353–362.
   Google Scholar
• Arora R, Katiyar SS, Kushwah V, et al. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study. Expert Opin Drug Deliv. 2017;14(2):165–177.
   PubMed Web of Science ®Google Scholar
• Singh KK, Tripathy S. Natural treatment alternative for psoriasis: a review on herbal resources. J Appl Pharm Sci. 2014;4(11):114–121.
   Google Scholar
• Agrawal U, Gupta M, Vyas SP. Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis. Artif Cells Nanomed Biotechnol. 2015;43(1):33–39.
   PubMed Web of Science ®Google Scholar
• Pradhan M, Singh D, Singh MR. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis. Chem Phys Lipids. 2015;186:9–16.
   PubMed Web of Science ®Google Scholar
• Reddy KR, Satyanarayana SV, Reddy VJ. Development and evaluation of clobetasol–loaded solid lipid nanoparticles for topical treatment of psoriasis. Int J Appl Pharm. 2019;11(5):143–150.
   Google Scholar
• Ghate VM, Kodoth AK, Shah A, et al. Colloidal nanostructured lipid carriers of pentoxifylline produced by microwave irradiation ameliorates imiquimod-induced psoriasis in mice. Colloids Surf B Biointerfaces. 2019;181:389–399.
   PubMed Web of Science ®Google Scholar
• Agrawal YO, Mahajan UB, Mahajan HS, et al. Methotrexate-loaded nanostructured lipid carrier gel alleviates imiquimod-induced psoriasis by moderating inflammation: formulation, optimization, characterization, in-vitro and in-vivo studies. Int J Nanomedicine. 2020;15:4763–4778.
   PubMed Web of Science ®Google Scholar
• Madan JR, Khobaragade S, Dua K, et al. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of apremilast. Dermatol Ther. 2020;33(3):3.
   Web of Science ®Google Scholar
• Ren G, Zhao Y. Preparation methods and thermal stability of calcipotriol solid lipid nanoparticles and efficacy in plaque psoriasis treatment. J Therm Anal Calorim. 2021;144(6):2091–2098.
   Web of Science ®Google Scholar
• Madan JR, Khude PA, Dua K. Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery. Int J Pharm Investig. 2014;4(2):60–64.
   PubMedGoogle Scholar
• Sharma A, Upadhyay DK, Sarma GS, et al. Squalene integrated NLC based gel of tamoxifen citrate for efficient treatment of psoriasis: a preclinical investigation. J Drug Deliv Sci Technol. 2020; 56: PartA. DOI:https://doi.org/10.1016/j.jddst.2020.101571.
   Google Scholar
• Sindhoor SM, Koland M. Topical delivery of apremilast loaded nanostructured lipid carrier based hydrogel for psoriasis therapy. J Pharm Res Int. 2021;33(28B):7–20.
   Web of Science ®Google Scholar
• Rapalli VK, Kaul V, Waghule T, et al. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition. Eur J Pharm Sci. 2020;152:105438.
   PubMed Web of Science ®Google Scholar
• Pradhan M, Alexander A, Singh MR, et al. Statistically optimized calcipotriol fused nanostructured lipid carriers for effectual topical treatment of psoriasis. J Drug Deliv Sci Technol. 2021;61:102168.
   Web of Science ®Google Scholar
• Reddy Kudamala R, Satyanarayana SV, Reddy Veeram J. Clobetasol-loaded dermal nanostructured lipid carriers for the treatment of imiquimod induced psoriasis in mice. Asian J Pharm. 2019;13(4):340.
   Web of Science ®Google Scholar
• Sathe P, Saka R, Kommineni N, et al. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Drug Dev Ind Pharm. 2019;45(5):826–838.
   PubMed Web of Science ®Google Scholar
• Avasatthi V, Pawar H, Dora P, et al. A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation. Pharm Dev Technol. 2015;20(1):1–9.
   PubMedGoogle Scholar
• Pradhan M, Singh D, Singh MR. Fabrication, optimization and characterization of Triamcinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis: application of Box Behnken design, in vitro and ex vivo studies. J Drug Deliv Sci Technol. 2017;41:325–333.
   Web of Science ®Google Scholar
• Pradhan M, Singh D, Murthy SN, et al. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis. Steroids. 2015;101:56–63.
   PubMed Web of Science ®Google Scholar
• Mitra A, Wu Y. Topical delivery for the treatment of psoriasis. Expert Opin Drug Deliv. 2010;7(8):977–992.
   PubMed Web of Science ®Google Scholar
• Domm S, Mrowietz U. Combination therapy in the treatment of psoriasis. J Dtsch Dermatol Ges. 2011;9(2):94–98.
   PubMed Web of Science ®Google Scholar
• Lin Y-K, Huang Z-R, Zhuo R-Z, et al. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomedicine. 2010;5:117–128.
   PubMed Web of Science ®Google Scholar
• Armanious M, Vender R. A review of drug-drug interactions for biologic drugs used in the treatment of psoriasis. J Cutan Med Surg. 2021;25(1):38–44.
   PubMed Web of Science ®Google Scholar
• Ferreira M, Barreiros L, Segundo MA, et al. Topical co-delivery of methotrexate and etanercept using lipid nanoparticles: a targeted approach for psoriasis management. Colloids Surf B Biointerfaces. 2017;159:23–29.
   PubMed Web of Science ®Google Scholar
• Sonawane R, Harde H, Katariya M, et al. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis. Expert Opin Drug Deliv. 2014;11(12):1833–1847.
   PubMed Web of Science ®Google Scholar
• Qadir A, Aqil M, Ali A, et al. Nanostructured lipidic carriers for dual drug delivery in the management of psoriasis: systematic optimization, dermatokinetic and preclinical evaluation. J Drug Deliv Sci Technol. 2020;57:101775.
   Web of Science ®Google Scholar
• Iriventi P, Gupta NV. Topical delivery of curcumin and caffeine mixture-loaded nanostructured lipid carriers for effective treatment of psoriasis. Pharmacogn Mag. 2020;16(68):206.
   Web of Science ®Google Scholar
• Viegas JSR, Praça FG, Caron AL, et al. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. Drug Deliv Transl Res. 2020;10(3):646–660.
   PubMed Web of Science ®Google Scholar